Immunization, HepB3 in Iran, Islamic Republic of
Iran, Islamic Republic of: Immunization, HepB3 was 98.0% in 2024. ▲ Rising
Immunization, HepB3 in Iran, Islamic Republic of, 1994–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in Iran, Islamic Republic of is 98.0%, measured in 2024.
The figure is down 1.0% on the previous year and down 1.0% over ten years.
Over the whole period, immunization, hepb3 in Iran, Islamic Republic of peaked at 99.0% in 2000 and was at its lowest, 59.0%, in 1995.
That places Iran, Islamic Republic of 19th out of 188 countries with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 31 years of available data.
Immunization, HepB3 in Iran, Islamic Republic of, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1994 | 62.0% | — |
| 1995 | 59.0% | -4.8% |
| 1996 | 84.0% | +42.4% |
| 1997 | 93.0% | +10.7% |
| 1998 | 94.0% | +1.1% |
| 1999 | 95.0% | +1.1% |
| 2000 | 99.0% | +4.2% |
| 2001 | 94.0% | -5.1% |
| 2002 | 99.0% | +5.3% |
| 2003 | 98.0% | -1.0% |
| 2004 | 95.0% | -3.1% |
| 2005 | 94.0% | -1.1% |
| 2006 | 98.0% | +4.3% |
| 2007 | 97.0% | -1.0% |
| 2008 | 99.0% | +2.1% |
| 2009 | 99.0% | +0.0% |
| 2010 | 99.0% | +0.0% |
| 2011 | 99.0% | +0.0% |
| 2012 | 98.0% | -1.0% |
| 2013 | 99.0% | +1.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 98.0% | -1.0% |
| 2016 | 99.0% | +1.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 99.0% | +0.0% |
| 2020 | 99.0% | +0.0% |
| 2021 | 98.0% | -1.0% |
| 2022 | 99.0% | +1.0% |
| 2023 | 99.0% | +0.0% |
| 2024 | 98.0% | -1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 81.2% | 59.0% | 95.0% | 6 |
| 2000s | 97.2% | 94.0% | 99.0% | 10 |
| 2010s | 98.8% | 98.0% | 99.0% | 10 |
| 2020s | 98.6% | 98.0% | 99.0% | 5 |
Countries ranked near Iran, Islamic Republic of
More health data for Iran, Islamic Republic of
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Population ages 50-54, male, annual growth rate 2.48 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0303 units per person (2025)
- Population ages 55-59, female, annual growth rate 4.39 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0246 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Iran, Islamic Republic of?
- Immunization, hepb3 in Iran, Islamic Republic of was 98.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Iran, Islamic Republic of?
- The highest recorded value was 99.0% in 2000.
- What is the lowest immunization, hepb3 recorded in Iran, Islamic Republic of?
- The lowest recorded value was 59.0% in 1995.
- How does Iran, Islamic Republic of rank for immunization, hepb3?
- Iran, Islamic Republic of ranks 19th out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in Iran, Islamic Republic of?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is rising.
- Where does this Iran, Islamic Republic of data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 31 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.